India’s quality drive is moving beyond factories

The proposed expansion of the Zero Defect Zero Effect (ZED) programme to service-sector MSMEs could bring structured quality standards to hospitality, tourism, healthcare and transport. But its success will depend on whether certification translates into better business practices and customer experiences.

India's effort to improve the quality and competitiveness of its micro, small and medium enterprises (MSMEs) is preparing to move beyond factory floors. The government's proposed expansion of its Zero Defect Zero Effect (ZED) certification programme to service-sector businesses could bring a new dimension to how smaller enterprises measure operational efficiency, service quality and environmental responsibility.

The move is significant because services account for a substantial part of India's MSME ecosystem, yet many smaller service businesses operate without the structured quality-management systems commonly associated with manufacturing. From accommodation providers and restaurants to transport operators, travel agencies and hospitals, the proposed expansion could encourage businesses to adopt more consistent processes and measurable performance standards.

India's proposed expansion of ZED certification could bring structured
quality benchmarks to service-sector MSMEs

According to a report by The Economic Times, the Ministry of Micro, Small and Medium Enterprises has prepared a framework to extend ZED certification to service enterprises. Around 20 assessment parameters have reportedly been identified, covering timely service delivery, service quality management, facility management, process control, customer management and the management of partners, vendors, franchisees and outsourced operations.

The proposed initial coverage includes transport, accommodation, food and beverage services, travel agencies, tour operators and hospitals. If implemented effectively, the expansion could provide smaller businesses in these sectors with a structured framework to identify operational weaknesses, improve service consistency and strengthen their competitiveness.

From manufacturing excellence to service quality

The ZED initiative is built around two principles. Zero Defect refers to delivering quality with minimal errors, defects and wastage. Zero Effect focuses on reducing the environmental impact of business operations through more responsible resource use, energy efficiency and waste management.

Launched in April 2022 under the MSME Champions Scheme, the existing programme encourages manufacturing enterprises to improve production processes, adopt quality standards, increase productivity and reduce their environmental footprint.

Importantly, the inclusion of service-sector MSMEs was already envisaged in the original programme design. The Ministry's official Zero Defect Zero Effect (ZED) framework outlined a two-phase implementation, with manufacturing enterprises covered in the first phase and service-sector businesses proposed for inclusion in the second. The framework also envisaged collecting additional information on MSME performance to help develop a National MSME Competitiveness Index.

The latest reported development therefore represents a move towards putting that second phase into practice, rather than an entirely new direction for the programme.

The distinction matters. While manufacturing quality can be assessed through product specifications, production processes, defect rates and resource consumption, service quality is more complex. It involves the consistency of customer interactions, reliability of delivery, staff practices, facility management and the ability to fulfil commitments.

A hotel, for instance, may have well-maintained facilities but still struggle with inconsistent housekeeping, delayed services or inadequate customer grievance handling. Similarly, a travel agency may offer competitive packages but fail to maintain consistency in its dealings with customers and suppliers.

The proposed assessment parameters suggest that the government intends to look beyond the physical infrastructure of service businesses and examine how they manage their operations.

An opportunity for hospitality and tourism businesses

The proposed inclusion of accommodation providers, food and beverage businesses, travel agencies and tour operators is particularly relevant to India's hospitality and tourism industries.

These businesses often operate in a fragmented market, with enterprises ranging from established organised companies to small, independently owned establishments. Their ability to deliver reliable service can influence customer confidence, repeat business and their access to larger commercial opportunities.

For smaller hotels and accommodation providers, structured facility management, housekeeping processes, service standards and customer feedback systems could help reduce inconsistencies. Restaurants and food-service businesses could benefit from stronger operational controls, supplier management and more systematic service delivery.

Travel agencies and tour operators, meanwhile, depend heavily on coordination with airlines, hotels, transport providers, local operators and other service partners. Managing these relationships effectively can be as important as the quality of the service offered directly to customers.

A structured quality framework could help such businesses move away from informal, owner-dependent operating practices towards documented procedures and more consistent service delivery.

However, the assessment process will need to recognise that these businesses have different operating models, resources and customer expectations. Applying identical benchmarks across a small travel agency, a restaurant and a hospital would risk overlooking the fundamental differences between them.

The challenge will be to establish common quality principles while developing sector-specific assessment requirements.

Certification must translate into commercial value

The existing ZED programme offers three certification levels: Bronze, Silver and Gold. Its approach goes beyond issuing certificates, incorporating assessment, guidance, handholding and managerial and technological interventions to help enterprises improve their operations.

The programme is voluntary, and its stated objective is to provide MSMEs with a roadmap towards greater competitiveness.

The scale of existing participation offers some indication of the initiative's reach. According to the ZED portal figures reported by ET, approximately 10.9 lakh manufacturing MSMEs have registered under the scheme. Around 7.7 lakh have received Bronze certification, while approximately 11,000 and 6,000 have achieved Silver and Gold certification, respectively.

These figures demonstrate the programme's reach, but registrations and certifications alone cannot establish how much participating businesses have improved. The more meaningful measures would be improvements in productivity, reduced wastage, better resource utilisation, fewer operational failures and stronger customer satisfaction.

This distinction will become even more important when the programme enters the services sector. A certificate may establish that a business has met specified assessment requirements. It cannot, by itself, guarantee a consistently good customer experience.

Affordability and accessibility will also matter. Smaller service enterprises may lack dedicated quality-management teams, specialised consultants or the financial resources to undertake extensive operational changes. The availability of training, handholding and financial assistance could therefore influence participation.

The government will also need to clarify whether the existing certification structure, eligibility conditions and financial support provisions will be extended to service-sector businesses. The current official ZED FAQs describe the existing scheme as manufacturing-focused and say that a service-sector model is under development. The proposed benefits for services should therefore not be assumed to be identical to those currently available to manufacturers.

Preparing MSMEs for wider markets

The reported development also has an international dimension. ET says the ministry has developed four to five additional parameters for MSME exporters, including export documentation, product traceability and origin verification.

These requirements could help businesses strengthen their ability to demonstrate compliance with international quality expectations and participate in global value chains. However, the exact scope and implementation of these additional parameters will need to be established through the formal framework.

Ultimately, the proposed expansion of ZED represents an opportunity to broaden India's quality-improvement agenda. Its significance lies not simply in bringing more businesses under a certification programme, but in encouraging smaller enterprises to view quality, operational discipline and sustainability as integral to their long-term competitiveness.

For the initiative to succeed, the emphasis must remain on improvement rather than the certificate itself. If service-sector MSMEs can use the framework to deliver more reliable services, manage resources better and earn greater customer confidence, ZED could become a meaningful instrument of competitiveness.

The real test will be whether India's service businesses become measurably better at what they do, not simply whether more of them acquire another certificate.

#MSMEIndia #ZEDCertification #ZeroDefectZeroEffect #MSMESector #IndianEconomy #ServiceSector #QualityManagement #MakeInIndia #BusinessCompetitiveness #SustainableBusiness

The Balcony Jungle: A split-second ambush on a mango leaf

There is an entire world unfolding on the green leaves right outside our windows—a world operating on micro-seconds, incredible spatial awareness, and lethal precision.

Earlier today, while checking on the tender new leaves of my balcony mango plant, a tiny figure caught my eye. Resting on one of the leaves was a small, uniquely patterned spider—decidedly different from the usual web-weavers I often see around the potted plants. Curious to capture the details, I brought out my phone camera and managed to get a clear close-up.

Calm before the strike: A female Two-striped Jumping Spider
(Telamonia dimidiata) waiting on the mango leaf

As I shifted angles for a second shot, I noticed a fly resting on another leaf just a short distance away, directly in the line of sight of my eight-legged subject. Framing them both in a single shot seemed like the perfect moment to capture. But before I could hit the shutter, the spider vanished in a blur.

In a fraction of a second, the fly was gone too.

Assuming the fly had simply flown off and spooked the spider, I began searching nearby leaves and the surrounding pots. That was when I looked beneath one of the lower mango leaves—and was left in absolute awe.

Mission accomplished: Tucked beneath the leaf with its catch

The spider hadn't missed. What felt like a sudden disappearance to my eyes was a masterfully calculated leap. She had calculated the trajectory, timed the jump to the exact moment the fly attempted to take off, and intercepted it mid-air before retreating under the leaf to secure her meal.

I later identified her as a female Two-striped Jumping Spider (Telamonia dimidiata), a member of the Salticidae family. Unlike traditional web builders, jumping spiders rely on their extraordinary vision—powered by eight eyes including two large principal eyes that judge depth and distance with uncanny accuracy—and hydraulic pressure within their legs to launch themselves up to fifty times their own body length.

We often look for wild nature in distant reserves and dense forests. But moments like this remind us that the natural world isn't somewhere else. It’s right here on our balconies, thriving in silence, teaching us patience, awareness, and quiet wonder..

#JumpingSpider #TelamoniaDimidiata #MacroPhotography #UrbanWildlife #BalconyGarden #NatureInFocus #Salticidae #MacroNature #WildlifePerfection #MacroMoments #InsectWorld #BalconyJungle #NatureBrilliance #MacroWorld #MiniWilderness #NatureIsAmazing

Can India's gig economy deliver security alongside opportunity?

India's gig economy has created a new employment landscape. Food delivery executives, ride-hailing drivers, e-commerce delivery personnel and thousands of other platform workers now form an essential part of the country's urban economy. Yet, for many of them, the flexibility of earning through digital platforms comes with a significant trade-off: limited access to the social security protections traditionally associated with employment.

A proposed government initiative could begin addressing this gap. The Centre is considering a 2% transaction-based contribution from digital aggregators to finance social security benefits for more than 12 million gig and platform workers. The proposal, reported by The Economic Times on November 4, 2026, could mark an important development in India's attempt to extend welfare protection to a workforce that has grown alongside its digital economy.

The proposal is particularly significant because it seeks to make the platforms that facilitate this economic activity contribute towards the welfare of the people who deliver the services.

A growing workforce with an uncertain safety net

The scale of India's gig economy makes the issue increasingly difficult to ignore.

According to the Economic Survey 2025-26, India's gig workforce increased from 7.7 million in FY2021 to 12 million in FY2025, registering growth of 55%. Gig workers now account for more than 2% of the country's workforce. The non-agricultural gig workforce is projected to reach 6.7% of the workforce by 2029-30, contributing an estimated ₹2.35 lakh crore to GDP.

Behind these numbers lies a workforce with widely differing economic circumstances. Some people use platform work to supplement their regular income, while others depend on it as their principal source of livelihood.

India's growing gig economy depends on millions of workers whose access to
employment-linked social security remains limited

For many, however, income remains uncertain. The Economic Survey estimates that around 40% of gig workers earn less than ₹15,000 a month. It also highlights income volatility, limited access to credit and concerns arising from algorithm-driven work allocation, performance monitoring and wage determination.

Unlike conventional salaried employment, platform-based work does not automatically provide a comprehensive package of health insurance, paid leave, retirement savings and other employment-linked benefits.

An accident, prolonged illness or loss of earning capacity can therefore have serious financial consequences for a worker and the family dependent on that income.

The proposed social security initiative seeks to address at least some of these vulnerabilities.

Why the government is reconsidering the funding formula

The proposed 2% contribution is not entirely new in principle. The Code on Social Security, 2020 already provides a statutory framework for extending social security to gig and platform workers.

Section 114 provides for aggregator contributions at a rate between 1% and 2% of annual turnover, subject to a ceiling of 5% of the amount paid or payable to gig and platform workers.

The legislation also permits schemes to be funded wholly through aggregator contributions or through a combination of contributions from different sources.

What the government is now reportedly considering is a change in the way the contribution is calculated.

Under the reported proposal, the contribution would be linked to transactions rather than the aggregator's overall turnover.

The distinction matters because digital platforms operate through different commercial models.

Consider two hypothetical businesses handling transactions worth ₹100 each. A commission-based platform might record only ₹20 as its revenue, while an inventory-led business might record the entire ₹100 as revenue. Although both facilitate comparable transaction values, their reported turnover could differ substantially.

A contribution calculated purely on accounting turnover could therefore produce different liabilities for businesses handling similar economic activity.

The government's reported preference for a transaction-linked approach is intended to address this disparity and ensure that one category of aggregator does not end up subsidising another.

There is, however, an important detail still requiring clarification: what exactly constitutes the chargeable transaction? Whether the calculation is based on the gross transaction value, the platform's attributable revenue or another measure will have a significant bearing on the final financial liability.

What workers could gain

According to the Economic Times report, the proposed scheme is expected to provide life and disability insurance, accident insurance, health benefits and maternity benefits.

These are important areas of protection for a workforce exposed to occupational risks and uncertain incomes.

The proposed mechanism envisages contributions from digital aggregators being channelled
into a social security framework to provide eligible gig and platform workers
with insurance and other welfare benefits

For a delivery worker, for instance, accident insurance could provide financial support following an injury that prevents the person from working. Health coverage could reduce the financial burden of medical treatment, while maternity benefits could provide support to women workers who might otherwise have limited access to such protection.

The reported funding arrangement envisages aggregators financing the scheme through the Social Security Fund, without direct contributions from the Centre or the workers.

However, pension, provident fund and other old-age benefits may be introduced at a later stage. The government is reportedly considering the nature of workers' long-term association with platforms before extending such benefits.

This sequencing raises an important question. If the objective is to provide comprehensive social security, how will the system eventually address retirement savings and financial security in old age?

Insurance can protect workers against specific risks, but it cannot substitute for a long-term income and retirement protection framework.

The platforms have their own concerns

The proposed change also reflects the growing tension between worker welfare and the economics of digital platforms.

Aggregators have argued that calculating contributions on turnover can produce distortions because different companies recognise revenue differently. Their representations have helped bring the transaction-based approach into consideration.

For businesses operating on relatively thin margins, an additional statutory contribution could also affect operating costs.

The financial impact will depend on the final definition of a transaction, the applicable rate, the categories of businesses covered and the treatment of different revenue streams.

There is also the question of who ultimately bears the cost.

Although the reported proposal places the funding responsibility on aggregators, companies could potentially respond by adjusting delivery charges, platform fees, commissions, promotional incentives or other components of their business models.

Some of these costs could eventually reach consumers. Others could affect the earnings opportunities available to workers.

These are possibilities rather than established outcomes. The extent of any cost transfer will depend on competition, pricing power, operating margins and the final regulatory framework.

The challenge for policymakers is to ensure that the contribution improves worker protection without creating unintended consequences that undermine the very livelihoods it is intended to support.

From registration to meaningful protection

Another critical consideration is the practical administration of the proposed scheme.

The National Social Security Board for Unorganised Workers and Gig and Platform Workers was officially notified by the Ministry of Labour and Employment on 30 October 2026. The Board is expected to recommend, oversee and monitor welfare schemes, with representation from government, aggregators, workers and other stakeholders.

According to the Economic Times, the Board is expected to finalise the scheme's contours in November, with a possible introduction in 2027.

The report also indicates that workers will need to satisfy minimum work requirements to qualify for benefits. The reported criteria include 90 days of work with a single aggregator during a financial year, or 120 days cumulatively when working across multiple platforms.

This is particularly relevant because gig work is not always a continuous engagement with one company. Workers frequently move between platforms depending on demand, incentives and earning opportunities.

A social security framework must therefore recognise the realities of multi-platform employment.

Registration, eligibility verification, contribution tracking and claims settlement will need to work across different aggregators. Workers should not lose access to protection simply because they change platforms or move between cities.

Equally important will be transparency in the collection and utilisation of funds, accessible grievance redressal and straightforward insurance claim procedures.

A welfare framework must go beyond the levy

India's proposed initiative comes at a time when governments across the world are reassessing the relationship between digital platforms and the people who work through them.

The Economic Survey 2025-26 points to international developments involving employment classification, algorithmic transparency and worker protection. These discussions underline that social security is only one part of the larger debate surrounding the future of platform employment.

India's immediate priority is to establish a workable funding mechanism and extend meaningful protection to a rapidly expanding workforce.

But the success of the proposed initiative cannot be measured simply by the amount collected from aggregators or the number of workers registered.

It must be measured by whether a delivery executive injured during work can access timely financial assistance, whether a driver can obtain affordable healthcare, whether a woman platform worker receives meaningful maternity protection and whether workers can retain their benefits when their working arrangements change.

The proposed 2% contribution could provide the financial foundation for such protection. Its real significance, however, will depend on how effectively the government translates the proposal into accessible, dependable and portable benefits.

For India's gig workers, the promise of flexibility should not have to mean living without a safety net.

#GigEconomy #GigWorkers #SocialSecurity #PlatformEconomy #FutureOfWork #WorkerWelfare #LabourReforms #DigitalIndia #GigWorkerRights #PlatformWorkers

India’s data centre boom will be tested by power

India is preparing for one of its biggest digital infrastructure expansions. More than ₹3 lakh crore is expected to flow into data centres over the next four financial years, as artificial intelligence (AI), cloud computing and rising digital consumption reshape demand for computing capacity. Yet, behind this investment opportunity lies a less glamorous but far more fundamental requirement: electricity.

India's installed data centre capacity is expected to increase five-fold to approximately 7.5 gigawatts (GW) by March 2030, according to a CRISIL Ratings assessment released on November 3, 2026. The expansion will involve substantial capital investment, with developers seeking to build facilities capable of supporting increasingly demanding computing workloads.

India's data centre industry is preparing for a major expansion as demand for AI computing and cloud services accelerates

The projections underline India's growing importance in the global digital infrastructure landscape. However, they also raise a critical question: can the country's power infrastructure, transmission networks and supporting resources keep pace with the ambitions of data centre developers?

The answer could determine how successfully India converts the growing demand for digital services and AI computing into a sustainable investment opportunity.

The AI effect is changing the economics of data centres

Data centres are the physical backbone of the digital economy. They house the servers, storage systems and networking equipment that enable businesses, governments and individuals to access online services, process information and store data.

Their importance is increasing as organisations move more operations to the cloud and adopt data-intensive technologies. The emergence of generative AI has added another dimension to this demand.

Unlike conventional computing applications, many AI workloads require substantial processing power. Training and running sophisticated AI models involves large numbers of specialised processors working together. This increases the need for high-performance computing infrastructure, reliable electricity and advanced cooling systems.

The demand is already reflected in India's expanding data centre market. Cushman & Wakefield's India Data Centre Market H1 2026 report estimated operational capacity at nearly 1.8 GW, with a development pipeline of approximately 3.9 GW. The research also identified cloud adoption, AI workloads and enterprise digitalisation as important growth drivers.

CRISIL's projected expansion to 7.5 GW by March 2030 points to the scale of the next investment cycle.

The opportunity extends beyond companies operating data centres. Construction, electrical equipment, power generation, transmission, cooling technologies, networking and engineering services could all benefit from the expansion.

However, the industry is particularly capital-intensive. Developers must invest heavily in land, buildings, electrical systems, servers and cooling infrastructure before facilities begin generating meaningful revenue.

India's cost advantage is attracting investment

India has several advantages in competing for a larger share of the global data centre market.

According to CRISIL Ratings, development costs are approximately one-fifth lower than in several competing Asia-Pacific markets. More competitive land, construction and labour costs contribute to this advantage.

The cost difference is also reflected in rentals, which CRISIL estimates are 30–35% lower than in peer markets.

For international cloud service providers and hyperscalers, these economics make India an attractive destination for expanding computing infrastructure.

Policy support is adding to the investment proposition. The Union Budget 2026–27 proposed a tax holiday until 2047 for eligible foreign companies providing cloud services to global customers using data centre services in India, subject to specified conditions. The measure is intended to provide greater long-term tax certainty and encourage investment in domestic digital infrastructure.

India's ability to develop large campuses powered by renewable energy could further strengthen its position, particularly as international technology companies face increasing pressure to address the environmental impact of their operations.

But competitive costs and tax incentives can attract investment only up to a point. Developers ultimately need dependable electricity, adequate transmission capacity and the ability to commission projects on schedule.

Three cities face a significant power challenge

This is where the scale of India's planned expansion becomes particularly important.

CRISIL estimates that approximately three-fourths of the upcoming data centre capacity of around 6 GW is expected to be developed in Visakhapatnam, Mumbai and Hyderabad.

The concentration of investment in these locations could place considerable demands on their electricity infrastructure.

Reliable electricity supply and transmission infrastructure will be critical to India's data centre expansion

By fiscal 2030, the projected data centre capacity in Visakhapatnam could equal approximately 80% of its current peak power demand. The corresponding ratios for Mumbai and Hyderabad are estimated at around 60% and 20%, respectively.

These comparisons highlight the scale of the proposed infrastructure additions. They do not represent the projected percentage increase in each city's electricity consumption, but they indicate why grid connectivity and transmission augmentation will be critical.

A data centre requires a continuous and dependable power supply. Interruptions can affect servers, networks and the digital services hosted within the facility. Developers therefore need reliable grid connections, backup arrangements and adequate electrical infrastructure.

The challenge extends beyond supplying electricity to individual projects. Transmission networks must be capable of delivering the additional power to locations where large data centre campuses are being established.

The government has also recognised the growing electricity requirements of the sector. A Ministry of Electronics and Information Technology statement in March 2026 cited a Ministry of Power estimate of 13.56 GW in data centre electricity demand by 2031–32. A subsequent parliamentary update in July reported an additional projected load of 26.3 GW from AI data centres by the same period. The figures reflect different stated scopes and estimates, rather than a directly comparable revision of the same measure.

The larger message, however, is clear: data centre growth is becoming an increasingly important consideration in electricity planning.

Long-term contracts offer reassurance, but not immunity

Despite the infrastructure challenges, the demand outlook provides developers with an important financial advantage.

CRISIL reports that nearly half of upcoming capacity is already committed under long-term contracts. More than 95% of capacity currently under construction has also been contracted.

Existing facilities are operating at approximately 90% utilisation, indicating strong demand for available capacity.

An important development is the lengthening of customer contracts. Contract tenures have increased to 15–20 years from 10–12 years earlier.

Such agreements provide developers with greater revenue visibility and help reduce the risk of investing in facilities without confirmed customers. They also make it easier to plan financing and assess the potential returns from large projects.

However, the growing dependence on hyperscalers presents another challenge.

CRISIL expects hyperscalers to account for 75–80% of industry capacity by fiscal 2030, compared with 60–65% in fiscal 2026.

These large technology companies are important customers because of their substantial and sustained computing requirements. But their growing influence could also strengthen their bargaining power.

As more capacity becomes available and developers compete for large contracts, pressure on rentals could affect project returns. Long-term agreements provide revenue visibility, but they do not automatically protect developers from future pricing pressures or changes in customer requirements.

There is also the question of contract renewals. CRISIL notes that a meaningful track record of renewals has yet to be established in the industry. While high migration costs and the capital expenditure involved in replacing infrastructure could encourage customer retention, this remains an aspect to watch as the market matures.

The financial burden comes before the returns

The industry's investment cycle also creates a financing challenge.

Data centre projects require substantial capital expenditure well before they generate operating cash flows. According to CRISIL, investments typically precede cash generation by 24–36 months.

This means developers must carry significant financial commitments during construction and commissioning.

Debt levels are therefore expected to remain elevated over the medium term. As projects become operational and utilisation increases, stronger cash flows should gradually improve their financial position.

However, delays in obtaining approvals, securing power connections or completing construction could extend the period before revenue begins flowing.

Cost overruns or slower-than-expected customer demand could further weaken project economics.

The distinction between contracted capacity and operational capacity is important here. A signed customer agreement provides confidence in future demand, but the developer must still complete the facility, secure the necessary infrastructure and commission it before the contracted capacity can generate revenue.

Sustainability will be another test

Power availability is not the only resource challenge confronting the industry.

Data centres also require cooling systems to manage the heat generated by densely packed servers and computing equipment. As AI workloads increase, developers will need to accommodate higher power density and more advanced cooling technologies.

Water availability, land use and the environmental impact of large facilities will also require attention.

Higher computing intensity is increasing the importance of advanced cooling technologies in modern data centres

The government has begun addressing these issues through its policy framework. NITI Aayog's Data Centre Evaluation Framework, released in October 2026, encourages states to assess proposed investments across five areas: power and energy, water and cooling, siting and environmental sustainability, economic and strategic value, and policy, governance and implementation.

The framework recommends evaluating grid readiness, renewable energy and storage-backed power, as well as water availability and the impact on existing public resources.

These considerations are important because the economic value of a data centre investment cannot be measured only by the capital committed by its developer. Its long-term viability also depends on whether the supporting infrastructure and natural resources can sustain its operations.

The real test begins now

India's data centre opportunity is substantial. Growing AI adoption, cloud computing, enterprise digitalisation and rising data consumption provide a strong foundation for further investment.

The country also has competitive development costs, an increasingly supportive policy environment and growing interest from international technology companies.

But the next phase of growth will demand more than investment announcements and construction plans.

Power connectivity, transmission infrastructure, timely approvals, financial discipline and technological upgrades will determine whether the proposed capacity additions can be delivered efficiently.

For developers, the challenge will be to build facilities that remain commercially viable and technologically relevant over the long term. For policymakers and state governments, it will be to ensure that infrastructure planning keeps pace with private investment without placing unsustainable pressure on electricity, water and other resources.

India may be entering a major data centre investment supercycle. Whether it can turn that opportunity into lasting digital infrastructure strength will depend, to a considerable extent, on something far removed from the world of algorithms and artificial intelligence: its ability to deliver reliable power.

#DataCentres #IndiaDataCentres #ArtificialIntelligence #GenerativeAI #DataCentreInfrastructure #PowerInfrastructure #EnergyTransition #CloudComputing #DigitalIndia #DataCentreInvestment

Medicine price controls face a test as cancer treatment remains costly

Cancer treatment can be financially punishing long before a patient completes a course of medicines. The cost of a drug, the price printed on its pack and the amount ultimately charged by a hospital can be very different. For families already coping with the physical and emotional strain of cancer, understanding these differences is not an academic exercise. It can determine whether treatment remains affordable.

A new round of government-directed price revisions promises relief for patients buying several anti-cancer medicines. Yet the revised prices also expose a limitation in the way affordability is measured: reducing the price of some medicines does not necessarily make the most expensive treatments accessible, nor does it settle questions about the mark-ups added along the healthcare supply chain.

The issue has gained urgency following two developments. The National Pharmaceutical Pricing Authority (NPPA) has published revised maximum retail prices (MRPs) for non-scheduled anti-cancer medicines, with the new prices due to take effect on November 9, 2026. Separately, the Supreme Court has questioned the Centre and private hospitals over medicine pricing and the large gaps between procurement costs and the amounts charged to patients.

Together, these developments raise a larger question: can medicine price controls deliver meaningful relief if substantial costs remain outside their reach?

Sharp cuts, but not across the board

The NPPA’s revised price list, based on information received from companies up to October 28, 2026, shows that the impact varies considerably between products. Some generic cancer medicines face substantial reductions, while the listed prices of several high-cost patented brands remain unchanged. The list is an important record of the price revisions, but it should not be mistaken for a measure of what every patient will save on an entire course of treatment.

The difference is striking in the examples reported by The Economic Times and its pharmaceutical industry publication, ETPharma. Their reporting identifies Keytruda, a pembrolizumab injection marketed by MSD, among the high-priced medicines whose MRP remains unchanged. The revised list puts its 100 mg injection at ₹2,16,500 per vial. Tagrisso, an osimertinib treatment marketed by AstraZeneca, is also unchanged at ₹4,16,492.48 for a pack of 30 tablets.

These figures do not, by themselves, establish what a particular patient will pay after discounts, assistance programmes or hospital billing arrangements. Nor does an unchanged MRP automatically establish that a price is unlawful. They do, however, illustrate the limits of a price revision when some of the costliest products see no reduction in their listed retail prices.

The contrast with selected generic products is substantial. In the NPPA list, Mylan’s MyTera, an abiraterone acetate 250 mg tablet pack of 120, falls from ₹16,865 to ₹5,105.50 — a reduction of about 69.7%. Khandelwal Laboratories’ ABIRAT, containing the same active ingredient and pack size, falls from ₹36,088.81 to ₹4,064.48, a reduction of about 88.7%.

These examples show the potential for meaningful savings. They also underline why comparisons must be made carefully: brands containing the same active ingredient can start from very different MRPs, and the price of a pack is not the same as the total cost of treatment. Patients should discuss suitable alternatives with their treating doctors rather than switch medicines on price alone.

What does a price cap actually control?

The latest intervention concerns trade margins on 137 non-scheduled anti-cancer medicines, with the government setting a 30% cap and directing revised MRPs for covered formulations. The distinction between scheduled and non-scheduled medicines matters because the regulatory mechanisms are not identical.

In its March 2026 statement, the Department of Pharmaceuticals said that ceiling prices for 131 anti-cancer drugs had resulted in an average reduction of around 21% against the prices fixed under the National List of Essential Medicines, with estimated annual savings of approximately ₹294 crore. The government also pointed to subsidised treatment in public hospitals, the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana scheme, Jan Aushadhi outlets and AMRIT pharmacies as other routes to improving access. These are government-reported figures and measures; they do not establish the savings experienced by every household.

A trade-margin cap and a ceiling on the price of a medicine are not interchangeable. A margin cap seeks to limit the difference permitted within the distribution chain under the relevant framework. It does not necessarily mean that the underlying price charged by a manufacturer will fall by the same proportion. This distinction is particularly important for patented medicines, where the scope for reducing a final price may differ from that for generic products facing competition.

The policy’s impact must therefore be judged product by product. It is too early to conclude that the latest revisions have failed: they are due to take effect on 9 November. But the unchanged prices in the list make it equally difficult to claim that the measure will make all high-cost cancer treatment affordable.

The hospital bill is a separate challenge

The Supreme Court’s hearing on October 27, 2026, brought another part of the problem into focus: the difference between the price at which medicines or medical consumables are procured and the amount charged to patients.

According to reports by Moneycontrol and IANS, the bench questioned the Centre over the regulatory framework and cited an example of a drip line bought for ₹15 but billed to a patient at ₹250. The court also heard an account involving a cancer injection that a medical distributor said could be procured for ₹11,000 but was reportedly charged at ₹1.30 lakh by a hospital.

These were examples raised during proceedings, not evidence that every hospital applies comparable mark-ups. Hospital representatives argued that institutions must maintain round-the-clock facilities, ensure the quality of medicines and cover operating expenses. The bench questioned whether such costs justified steep differences in medicine prices and remarked that hospitals could not survive through “dacoity”.

The court reserved its verdict. Its observations should not be presented as a final ruling, but they sharpen the policy question: how should legitimate healthcare costs be recovered, and how should patients be protected from excessive or poorly explained charges?

The hospital-billing issue is related to, but distinct from, the NPPA’s revised MRPs. A lower MRP may help a patient purchasing a covered medicine, but it does not automatically resolve how hospitals price medicines and consumables, or how they disclose procurement costs, discounts and charges. Equally, an unchanged MRP does not prove that a hospital’s charge is excessive. Those questions require scrutiny of the product, the transaction and the applicable rules.

Measuring affordability at the point of care

For patients, the meaningful measure of success is not simply how many prices have been revised. It is whether the medicine they need is available, whether an appropriate lower-cost alternative exists, and what they must actually pay to receive treatment.

That calls for transparent, product-level price information; clear bills that distinguish medicines from other hospital charges; effective monitoring of compliance; and accessible information about legitimate generic alternatives and patient-assistance programmes. Public procurement and institutional negotiations may also matter where expensive patented medicines remain beyond the reach of many households.

None of these measures removes the need to fund research, maintain reliable medicine supplies or operate safe hospitals. But affordability cannot be judged only from the perspective of manufacturers, distributors or healthcare providers. It must also account for household incomes and the consequences when a patient cannot meet the bill.

The NPPA’s revised list offers tangible relief on some products, and those reductions should not be dismissed. But unchanged prices for several costly brands, alongside unresolved questions about hospital mark-ups, show why a price cap is only one part of a larger response.

The real test begins when the revised prices take effect: whether the savings reach patients, whether billing practices are transparent and whether people facing cancer can obtain appropriate treatment without being pushed into financial distress. Until affordability is assessed at that point of care, lower prices on paper will remain an incomplete measure of progress.

#AffordableHealthcare #DrugPricing #CancerCare #CancerTreatment #HealthcareCosts #NPPA #MedicinePrices #HospitalBilling #PatientRights #HealthcarePolicy

The government admits hospital pricing needs closer scrutiny

The Centre's acknowledgement of excessive hospital pricing has brought a longstanding problem into sharper focus. The challenge now is to protect patients without compromising access to medicines and medical care.

A hospital bill can contain far more than the cost of a doctor's consultation, a bed or a surgical procedure. Medicines, implants, injections and medical consumables can add substantially to the final amount. For patients undergoing cancer treatment or recovering from major surgery, these expenses can accumulate over weeks or months.

The problem is not simply that healthcare is expensive. It is that patients may have little information about the prices of the products used in their treatment, few opportunities to compare alternatives and limited freedom to question charges when their health is at stake.

Hospital bills are becoming a patient rights issue, as cancer drug mark-ups expose India's healthcare pricing dilemma
(AI generated representative image)

The Union government has acknowledged this concern before the Supreme Court, describing excessive pricing of medicines and consumables by hospitals as malpractice. In an affidavit reported by The Times of India on 23 October, the Centre highlighted mark-ups of 170% to 700% or more on some anti-cancer medicines and 100% to 1,000% or more on certain hospital consumables.

The figures are striking. But the more important question is what they reveal about the relationship between patients, hospitals and the businesses supplying healthcare products.

When patients cannot easily question the bill

A patient buying a medicine from a retail pharmacy may have an opportunity to compare brands, ask about alternatives or visit another shop. That freedom can disappear inside a hospital, particularly during an emergency or an extended course of treatment.

Patients and their families may not know which consumables are medically necessary, whether equivalent products are available or how much the hospital paid for them. When a doctor recommends a procedure and the hospital arranges the supplies, questioning individual prices can feel difficult.

The Centre's affidavit reportedly recognises this imbalance in bargaining power and access to information. It also raises concerns about hospitals purchasing medicines from manufacturers offering higher trade margins and subsequently charging patients the printed maximum retail price (MRP).

This distinction matters. A product sold at its MRP is not necessarily being sold illegally. But a substantial gap between the hospital's procurement price and the amount billed to a patient raises legitimate questions about pricing transparency and the way financial incentives influence purchasing decisions.

The concern extends beyond medicines. Consumables used during surgery, treatment and routine hospital care may appear relatively inexpensive individually, yet their cumulative cost can become significant.

For families paying directly for treatment, the final bill may therefore reflect not just the medical care received, but also the pricing arrangements governing the products used to provide it.

Cancer medicines expose the pricing dilemma

The issue becomes particularly serious when the medicines are required to treat life-threatening illnesses. Cancer patients may need several rounds of treatment, making the cost of medicines a recurring financial burden rather than a one-time expense.

The Centre has announced a proposed intervention to cap trade margins on selected non-scheduled anti-cancer medicines at 30% of their MRP. It expects the measure to reduce prices by 20% to 70% and save patients approximately ₹2,500 crore annually. These are government estimates, not savings already achieved. The medicines covered are to be identified through a separate process.

The Supreme Court, however, has questioned why the response should be confined to cancer medicines. During hearings in September and October, the court drew attention to substantial differences between the prices of medicines and medical supplies at different stages of the supply chain. It pressed the government to consider broader measures.

The Centre has argued that pricing interventions must account for distribution costs and the need to maintain supplies, including in remote areas. The court's scrutiny reflects a competing concern: a pricing system must not leave patients carrying an excessive financial burden simply because they cannot negotiate the cost of treatment.

The problem is also more complicated than setting a single percentage. Medicines, implants and consumables have different costs, supply chains and distribution requirements. A policy that works for one category may not be suitable for another.

A problem that predates the latest intervention

The current debate follows a Supreme Court judgment delivered on 4 March 2025 in Siddharth Dalmia and another versus Union of India and others.

The case concerned allegations that private hospitals compelled patients to buy medicines, devices, implants and consumables from hospital-linked pharmacies at inflated prices. The Court asked state governments to consider appropriate policy measures, while cautioning against interventions that could unreasonably discourage private healthcare providers. It did not rule that the allegations in the petition had been proved.

This distinction is important. The challenge is not to assume that every private hospital engages in malpractice, but to establish clear and enforceable rules that protect patients wherever unreasonable pricing occurs.

There is also a regulatory gap between medicines covered by existing price controls and other products used in hospitals. The Centre's own account acknowledges that more information is needed to understand the scale of the problem and design appropriate interventions.

The Supreme Court's next hearing in the current proceedings is scheduled for 27 October 2026.

Transparency must become part of patient care

Price regulation alone may not resolve every problem. Patients also need to know what they are being charged for, whether a prescribed product has a suitable alternative and whether they can obtain it elsewhere without compromising treatment.

Hospitals should be able to explain their charges clearly. Patients should receive itemised bills that distinguish medicines, consumables, procedures and other services. Where a hospital requires a particular product, the medical reason should be understandable to the patient or caregiver.

Regulators, meanwhile, need reliable data on procurement prices and actual billing practices. Without it, they risk introducing rules that are difficult to enforce or that fail to address the largest sources of excessive charges.

The government has acknowledged the problem. The court has demanded a wider examination of medicine pricing. The real test will be whether these developments lead to practical safeguards that patients can see in their bills.

Healthcare is not an ordinary consumer purchase. People often seek it when they have little time, limited information and no easy way to walk away. Protecting them requires more than recognising that prices can be excessive. It requires a system in which charges are transparent, rules are enforceable and the cost of treatment does not become an additional source of distress.

#HealthcareCosts #HospitalOvercharging #HealthcareAffordability #PatientRights #MedicalInflation #CancerTreatment #MedicinePrices #HealthcareReform #SupremeCourtOfIndia #HealthcareInIndia

From pump repairs to industrial problem-solving, PSUCHE is carving out its niche

An industrial pump rarely attracts attention when it works as expected. But when it fails repeatedly, struggles to handle the material it was selected for, or becomes difficult to replace, it can turn into a costly operational problem. For manufacturers, the challenge is not simply to repair the equipment. It is to understand why it failed and find a solution that works under actual operating conditions.

This is the problem-solving approach that, according to Vishal Garg, proprietor of PSUCHE Pumps & Systems, has shaped the company’s business since its establishment in 2018.

“The company began with pump selection, servicing and troubleshooting for critical, semi-critical and general industrial applications. Over time, experience gained from repairing pumps made by different manufacturers exposed recurring problems involving design limitations, unsuitable applications, material compatibility and mechanical failures,” said Garg.

PSUCHE's stated evolution from repair work to retrofit solutions and the manufacture of its own pump range provides the central thread of its business journey. Rather than treating a failed pump as an isolated maintenance issue, the company seeks to use that experience to develop equipment better suited to the demands of industrial processes.

It is a proposition that places application knowledge at the centre of the business.

Learning from failures

In industrial operations, choosing a pump involves more than matching a product to a required flow rate. The nature of the liquid, its chemical properties, operating pressure, temperature and the demands of the process can all influence the choice of equipment and materials.

A mismatch can result in repeated breakdowns, maintenance requirements and disruption. Replacing a failed unit with an identical model may not resolve the underlying problem if the original selection was unsuitable for the application.

“Our experience in servicing and troubleshooting pumps from different manufacturers gave us a practical starting point for addressing such challenges. Our approach is to draw on this experience when modifying equipment, developing retrofit solutions and manufacturing our own products,” said Garg.

The distinction matters. Repair work addresses an immediate problem; engineering-led problem-solving attempts to understand and correct its cause. For customers, the potential value lies in finding a technically appropriate solution rather than repeatedly dealing with the consequences of equipment failure.

Building a broader product proposition

The company’s product range covers several pump technologies used in different industrial applications. These include peristaltic hose pumps, electronically operated double diaphragm (EODD) pumps, air-operated double diaphragm (AODD) pumps, magnetic-drive centrifugal pumps, gear and single-screw pumps, canned motor pumps, and vertical long-shaft pumps with lengths of up to three metres.

This breadth gives PSUCHE a platform to address varied pumping requirements rather than concentrating on a single equipment category.

The technologies serve different purposes. Peristaltic pumps move fluids through a flexible hose, while diaphragm pumps use a moving membrane to transfer liquid. Gear and single-screw pumps use positive-displacement mechanisms, making them relevant to applications requiring controlled handling of certain fluids. Magnetic-drive and canned motor designs, meanwhile, can be considered where containing the pumped liquid and limiting leakage are important design priorities.

The appropriate choice depends on the process, fluid properties, operating conditions and the equipment's design limits. A broad catalogue alone does not guarantee suitability, but technical knowledge across multiple pump types can help a supplier evaluate alternatives when a standard replacement is not adequate.

According to Garg, the strategic opportunity is to combine the product range with the company's troubleshooting and retrofit experience, allowing PSUCHE to approach customer requirements as engineering problems rather than simply product enquiries.

Import substitution as a business opportunity

One of PSUCHE’s principal offerings is import-substitute pumps. The company identifies organisations including Tata Steel's Khopoli operations, Elementis Specialties, TechNova Imaging Systems, Gujarat Insecticides, Exide Industries, Balmer Lawrie and Jubilant Ingrevia among its customers for these pumps.

This proposition addresses a recognisable industrial procurement challenge. When an imported pump is difficult to source, has a long delivery period or belongs to an obsolete product line, an alternative may help a plant avoid prolonged dependence on the original supplier.

The Indian pump industry has an established role in replacement equipment and import substitution. The Indian Pump Manufacturers' Association (IPMA) has highlighted the importance of domestic pumps and responsive after-sales service in industrial applications. Industry commentary has also highlighted the role of localisation, material improvements and design customisation in strengthening the domestic sector.

For PSUCHE, the opportunity is not merely to offer an Indian-made alternative. A replacement must also meet the relevant technical requirements, fit the installation, work with the process fluid and demonstrate dependable performance. Customers may need drawings, performance curves, material specifications, testing records and service support before approving a substitute for an existing pump.

The company's ability to meet these requirements consistently is central to building confidence in its import-substitution proposition.

A service-led route to market

The company’s approach to attracting customers is relatively direct. “We invite prospective buyers to share pump datasheets, details of existing equipment or descriptions of application challenges so that we can evaluate the requirement and propose a technically suitable solution,” said Garg.

This suggests a consultative, application-led sales model. Instead of relying exclusively on standard product enquiries, the company seeks to understand the customer's operating problem before considering whether servicing, modification, retrofitting or a replacement pump is appropriate.

Such an approach is particularly relevant when a customer faces recurring failures, high maintenance requirements, obsolete equipment or extended import lead times.

It also creates an opportunity to build relationships through technical support. A successful repair or replacement can provide a starting point for further work at the same facility.

According to Garg, the company has handled pump repair requirements for organisations including ISRO, Balmer Lawrie and Exide Industries. These reported engagements indicate experience across a range of industrial requirements.

Serving diverse industrial requirements

PSUCHE identifies the chemical, pharmaceutical, oil and gas, fertiliser, aerospace, steel and specialty chemical industries among the sectors it serves.

These industries present demanding pumping requirements, from material compatibility and containment to reliability under particular operating conditions. However, the technical and regulatory requirements differ substantially between applications. A solution suitable for one process cannot automatically be assumed to meet the requirements of another.

This diversity makes application assessment important to the company's proposition. It also raises the need for clear technical documentation, appropriate testing and evidence that a particular pump is suitable for its intended duty.

For a smaller or specialist supplier, competing effectively may depend less on matching every large manufacturer's scale and more on identifying applications where technical responsiveness, customised solutions and replacement support matter to the buyer. This is a potential basis for PSUCHE to differentiate itself in the market.

Turning engineering experience into a lasting advantage

The company’s business model brings together three activities: troubleshooting existing equipment, developing solutions for problematic applications and supplying pumps designed to address identified requirements.

The combination offers a clear strategic logic. Servicing can reveal recurring problems; engineering and modification can help address them; and manufacturing creates an opportunity to turn the resulting knowledge into a product offering.

As Garg puts it, “Industrial customers ultimately need more than a pump that fits. They need equipment that performs reliably in the conditions for which it was selected, backed by a supplier capable of responding when problems arise.”

PSUCHE’s value proposition lies in combining practical pump servicing and troubleshooting experience with application-specific engineering, retrofit solutions and its own range of industrial pumps, helping customers address demanding pumping requirements with technically suitable solutions.

The opportunity for the company is to make its experience with pump failures the starting point for a more differentiated engineering business. Its ability to carve out a lasting niche will depend on translating that experience into reliable products, documented customer outcomes and solutions that meet the demands of real industrial operations.

#PSUCHEPumps #IndustrialPumps #PumpEngineering #IndustrialInnovation #ImportSubstitution #MakeInIndia #PumpMaintenance #ProcessEngineering #EngineeringSolutions #IndianManufacturing

लोकतंत्र या धनतंत्र? मस्क का यह विरोधाभास समझ से परे है

न्यू यॉर्क टाइम्स की यह रिपोर्ट एक बार फिर अमेरिकी लोकतांत्रिक प्रणाली में पैसे के बेहिसाब प्रभाव को उजागर करती है। 

एलन मस्क, जिन्होंने कभी राजनीति से दूरी बनाने और "बहुत कम खर्च करने" की बात कही थी, आज 2026 के मिडटर्म चुनावों में $366 मिलियन से अधिक की फंडिंग देकर रिपब्लिकन पार्टी के सबसे बड़े तारणहार और डोनर बनकर उभरे हैं। 

जब आम नागरिक वोट की ताकत से बदलाव की उम्मीद करता है, तब एक अकेले अरबपति द्वारा सुपर पीएसी (Super PACs) के जरिए करोड़ों डॉलर झोंक देना चुनावी निष्पक्षता पर गंभीर सवाल खड़े करता है।

मस्क अक्सर सोशल मीडिया पर व्यवस्था में पारदर्शिता, निष्पक्षता और फ्री स्पीच की वकालत करते हैं। लेकिन जब वे खुद पर्दे के पीछे से इतनी बड़ी वित्तीय ताकत का इस्तेमाल करके जनमत और चुनावी जमीन को प्रभावित करने की कोशिश करते हैं, तो उनकी बातें खोखली नजर आती हैं। 

ऐसे में उनके इस कदम पर यह कहावत सटीक बैठती है कि -- "जिनके अपने घर शीशे के होते हैं, वे दूसरों के घरों पर पत्थर नहीं फेंका करते।"

यदि आप खुद प्रणाली को अपनी दौलत से प्रभावित कर रहे हैं, तो दूसरों को नैतिकता का पाठ पढ़ाना बंद करना होगा। 

लोकतंत्र केवल सबसे अमीर लोगों के हितों की रक्षा का जरिया नहीं बन सकता।